U.S. allows Lou Gehrig's patients to try Insmed drug
WASHINGTON (Reuters) - U.S. regulators will allow experimental use of Insmed Inc's drug Iplex for some patients with Lou Gehrig's disease, the Food and Drug Administration said on Tuesday.<div class="feedflare">
<img src="http://feeds2.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"></img> (http://feeds.reuters.com/~ff/reuters/healthNews?a=WHUDfkQI0UE:DLGOU0POq4A:yIl2AUoC8zA) <img src="http://feeds2.feedburner.com/~ff/reuters/healthNews?i=WHUDfkQI0UE:DLGOU0POq4A:F7zBnMyn0Lo" border="0"></img> (http://feeds.reuters.com/~ff/reuters/healthNews?a=WHUDfkQI0UE:DLGOU0POq4A:F7zBnMyn0Lo) <img src="http://feeds2.feedburner.com/~ff/reuters/healthNews?i=WHUDfkQI0UE:DLGOU0POq4A:V_sGLiPBpWU" border="0"></img> (http://feeds.reuters.com/~ff/reuters/healthNews?a=WHUDfkQI0UE:DLGOU0POq4A:V_sGLiPBpWU)
</div><img src="http://feeds2.feedburner.com/~r/reuters/healthNews/~4/WHUDfkQI0UE" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/healthNews/~3/WHUDfkQI0UE/idUSTRE52969G20090310